Search

everythinglearnresearchcommunity

for

Search:↓

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Review determines effective, safe treatments for female hair loss.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Antibody treatments show promise for hair loss but need more research.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

Higher sebum levels are linked to more severe male baldness.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Hair loss in young men in Central India is linked to severe heart disease.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

There's no significant link between blood fat levels and male pattern baldness.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.